{{Rsnum
|rsid=3804513
|Gene=IL17A
|Chromosome=6
|position=52188399
|Orientation=plus
|GMAF=0.04362
|Gene_s=IL17A
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 100.0 | 0.0 | 0.0
| HCB | 86.8 | 13.2 | 0.0
| JPT | 76.2 | 21.4 | 2.4
| YRI | 98.3 | 1.7 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 86.8 | 13.2 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=23131423
|Title=Interleukin-17A genetic variants can confer resistance to brucellosis in Iranian population
}}

{{PMID Auto
|PMID=23652560
|Title=Genetic polymorphisms of interleukin 17A and interleukin 17F and their association with inflammatory bowel disease in a Chinese Han population
}}

{{PMID Auto
|PMID=17876645
|Title=Associations between HLA-DRB1, RANK, RANKL, OPG, and IL-17 genotypes and disease severity phenotypes in Japanese patients with early rheumatoid arthritis.
}}

{{PMID Auto
|PMID=17903294
|Title=Genome-wide association and linkage analyses of hemostatic factors and hematological phenotypes in the Framingham Heart Study.
|OA=1
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}